Patients approved for new therapies often face unexpected costs and insurance complications. A dedicated service could map out payment options.
The platform would explain treatment costs, insurance coverage, patient assistance programs, and alternative funding sources.
Hospitals might license it to improve patient experience, or patients could pay for premium concierge services.
Start with basic cost estimation for newly approved drugs in one cancer type.
Risk: Requires deep, constantly updated knowledge of healthcare reimbursement policies.